As investors clamored this past spring for opportunistic strategies, the media wrote the hedge fund industry’s obituary (again) and the pandemic raged – a shift was underway as managers boosted their private capital offerings
... Read more »
Last year was one for the record books for most biotech/healthcare-oriented hedge funds, but despite a global health emergency dispersion between managers seems to be attracting the attention of investors
... Read more »
Undeterred by global pandemic, market volatility and a shaky U.S. economic recovery, alternative investment managers moved ahead attracting new capital in macro, alternative credit and private equity opportunities
... Read more »
Crisis oriented funds are raising billions each week, and investors are still eager to put money to work in private equity, real assets, infrastructure, hedge funds and niche-credit strategies
... Read more »
Our May 6, 2020 webinar, How to Build Investor Trust in this Environment, is now available on demand
... Read more »
